Oral administration of calcitonin

Details Oral administration of calcitonin Oral administration of calcitonin

2007-05-24

2009-08-04

Tsang, Cecilia (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S012200, C530S300000, C530S307000

Reexamination Certificate

active

07569539

ABSTRACT:
Disclosed is a particular method of orally administering pharmaceutical compositions comprising calcitonin in combination with oral delivery agents, prior to the consumption of food in humans, and a method of treatment of disorders responsive to the action of calcitonin employing such method of administration; also oral calcitonin pharmaceutical compositions with particular ratios of the amount of oral delivery agent to the amount of calcitonin.

REFERENCES:
patent: 5629020 (1997-05-01), Leone-Bay et al.
patent: 7049283 (2006-05-01), Ault et al.
patent: 2002/0065255 (2002-05-01), Bay et al.
patent: 2002/0123459 (2002-09-01), Ault et al.
patent: 00/59480 (2000-10-01), None
patent: 02/45754 (2002-06-01), None
Fortical Nasal Spray for Osteoporosis Launched, from http://goliath.ecnext.com/coms2/gi—0199-4702616/FORTICAL-NASAL-SPRAY-FOR-OSTEOPOROSI, Oct. 1, 2005, pp. 1-3. Accessed May 14, 2009.

Affiliated with

Also associated with

Rating

Oral administration of calcitonin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral administration of calcitonin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral administration of calcitonin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4070333